Co-Authors
This is a "connection" page, showing publications co-authored by Radha Rajasingham and Elizabeth Okafor.
Connection Strength
1.691
-
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply. N Engl J Med. 2020 09 10; 383(11):1089.
Score: 0.892
-
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 06 01; 72(11):e835-e843.
Score: 0.237
-
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
Score: 0.227
-
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa602.
Score: 0.058
-
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
Score: 0.056
-
Symptoms of COVID-19 Outpatients in the United States. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa271.
Score: 0.056
-
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
Score: 0.055
-
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
Score: 0.055
-
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020 Apr; 7(4):ofaa130.
Score: 0.055